These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


114 related items for PubMed ID: 2514233

  • 1. Recombinant human interferon-beta suppresses the replication of HIV and acts synergistically with AZT.
    Williams GJ, Colby CB.
    J Interferon Res; 1989 Dec; 9(6):709-18. PubMed ID: 2514233
    [Abstract] [Full Text] [Related]

  • 2. Two-drug combinations of zidovudine, didanosine, and recombinant interferon-alpha A inhibit replication of zidovudine-resistant human immunodeficiency virus type 1 synergistically in vitro.
    Johnson VA, Merrill DP, Videler JA, Chou TC, Byington RE, Eron JJ, D'Aquila RT, Hirsch MS.
    J Infect Dis; 1991 Oct; 164(4):646-55. PubMed ID: 1716649
    [Abstract] [Full Text] [Related]

  • 3. Comparative assessment of antiretrovirals in human monocyte-macrophages and lymphoid cell lines acutely and chronically infected with the human immunodeficiency virus.
    Crowe SM, McGrath MS, Elbeik T, Kirihara J, Mills J.
    J Med Virol; 1989 Nov; 29(3):176-80. PubMed ID: 2533247
    [Abstract] [Full Text] [Related]

  • 4. Three-drug synergistic inhibition of HIV-1 replication in vitro by zidovudine, recombinant soluble CD4, and recombinant interferon-alpha A.
    Johnson VA, Barlow MA, Merrill DP, Chou TC, Hirsch MS.
    J Infect Dis; 1990 Jun; 161(6):1059-67. PubMed ID: 2345291
    [Abstract] [Full Text] [Related]

  • 5. In vitro evaluation of mismatched double-stranded RNA (ampligen) for combination therapy in the treatment of acquired immunodeficiency syndrome.
    Montefiori DC, Robinson WE, Mitchell WM.
    AIDS Res Hum Retroviruses; 1989 Apr; 5(2):193-203. PubMed ID: 2469450
    [Abstract] [Full Text] [Related]

  • 6. Human immunodeficiency virus (HIV)-infected tumor xenografts as an in vivo model for antiviral therapy: role of alpha/beta interferon in restriction of tumor growth in nude mice injected with HIV-infected U937 tumor cells.
    Puddu P, Locardi C, Sestili P, Varano F, Petrini C, Modesti A, Masuelli L, Gresser I, Belardelli F.
    J Virol; 1991 May; 65(5):2245-53. PubMed ID: 1901915
    [Abstract] [Full Text] [Related]

  • 7. Beta-interferon therapy in patients with poor-prognosis Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS). A phase II trial with preliminary evidence of antiviral activity and low incidence of opportunistic infections.
    Miles SA, Wang HJ, Cortes E, Carden J, Marcus S, Mitsuyasu RT.
    Ann Intern Med; 1990 Apr 15; 112(8):582-9. PubMed ID: 2109563
    [Abstract] [Full Text] [Related]

  • 8. Growth inhibitory effects of interferon-beta but not interferon-alpha on human glioma cells: correlation of receptor binding, 2',5'-oligoadenylate synthetase and protein kinase activity.
    Rosenblum MG, Yung WK, Kelleher PJ, Ruzicka F, Steck PA, Borden EC.
    J Interferon Res; 1990 Apr 15; 10(2):141-51. PubMed ID: 2140395
    [Abstract] [Full Text] [Related]

  • 9. Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines.
    Poli G, Orenstein JM, Kinter A, Folks TM, Fauci AS.
    Science; 1989 May 05; 244(4904):575-7. PubMed ID: 2470148
    [Abstract] [Full Text] [Related]

  • 10. Synergistic interaction of 2',3'-dideoxycytidine and recombinant interferon-alpha-A on replication of human immunodeficiency virus type 1.
    Vogt MW, Durno AG, Chou TC, Coleman LA, Paradis TJ, Schooley RT, Kaplan JC, Hirsch MS.
    J Infect Dis; 1988 Aug 05; 158(2):378-85. PubMed ID: 2841378
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Restriction of HIV replication in infected T cells and monocytes by interferon-alpha.
    Gendelman HE, Baca L, Turpin JA, Kalter DC, Hansen BD, Orenstein JM, Friedman RM, Meltzer MS.
    AIDS Res Hum Retroviruses; 1990 Aug 05; 6(8):1045-9. PubMed ID: 2121192
    [Abstract] [Full Text] [Related]

  • 18. Effect of 3'-azido-2',3'-dideoxythymidine (AZT) and neutralizing antibody on human immunodeficiency virus (HIV)-induced cytopathic effects: implication of giant cell formation for the spread of virus in vivo.
    Nakashima H, Tochikura T, Kobayashi N, Matsuda A, Ueda T, Yamamoto N.
    Virology; 1987 Jul 05; 159(1):169-73. PubMed ID: 3111083
    [Abstract] [Full Text] [Related]

  • 19. Synergistic activity of granulocyte-macrophage colony-stimulating factor and 3'-azido-3'-deoxythymidine against human immunodeficiency virus in vitro.
    Hammer SM, Gillis JM.
    Antimicrob Agents Chemother; 1987 Jul 05; 31(7):1046-50. PubMed ID: 2444155
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.